Abstract
In recent years, several PET tracers for monitoring the activity and expression of P-gp at the BBB have been tested. P-gp substrates such as [(11)C]verapamil and [(11)C]loperamide can be employed to visualize P-gp activity, but they display a moderate baseline uptake in the brain and formation of radiolabeled metabolites which hamper the interpretation of PET data. P-gp inhibitors such as [(11)C]elacridar, [(11)C]laniquidar and [(11)C]tariquidar have been tested to investigate P-gp expression and the results need further investigation. Recently, we developed MC18, MC266 and MC80, that have been characterized as an inhibitor, substrate and inducer of P-gp both by in vitro assays and in the everted gut sac method. These compounds have been radiolabelled with (11)C and been evaluated in vivo. In the present review, we compare the outcome of biological in vitro assays and the corresponding in vivo PET data for the P-gp inhibitors [(11)C]MC18 and [(11)C]elacridar, the P-gp substrates [(11)C]MC266 and [(11)C]verapamil, the P-gp inducer [(11)C]MC80 and the P-gp modulator cyclosporin A. Since a satisfactory overlap was found comparing in vivo results and the corresponding in vitro findings, the proposed biological in vitro assays could...Continue Reading
Citations
Jul 23, 2013·PloS One·Chuan WangYimin Hua
Apr 2, 2013·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Cristina BolzatiNicola Antonio Colabufo
Jul 6, 2013·Nuclear Medicine and Biology·Stina SyvänenHeidrun Potschka
Dec 14, 2012·Journal of Pharmacological and Toxicological Methods·Maria Grazia PerroneNicola Antonio Colabufo
Nov 26, 2015·Journal of Clinical Pharmacy and Therapeutics·Z R TanL S Wang
Aug 18, 2012·Nuclear Medicine and Biology·Xiaofeng BaoVictor W Pike
Nov 29, 2011·Drug Discovery Today·Lei ChenTingjun Hou
Apr 18, 2014·Pediatric Cardiology·Chuan WangYimin Hua
Sep 3, 2013·Neuropharmacology·Markus PielFrank Rösch
May 3, 2014·The International Journal of Biochemistry & Cell Biology·Jun-Feng ShiYu-Jie Sun
Sep 14, 2016·Expert Opinion on Therapeutic Patents·Inder Pal Singh, Purvi Shah
Apr 12, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mariline GameiroFernando Remião
Jan 9, 2015·Archives of Pharmacal Research·Yan ZhouXin'an Wu
Feb 12, 2015·Clinical Pharmacology and Therapeutics·R M RaaphorstG Luurtsema
Nov 14, 2015·ChemMedChem·Mariangela CantoreGert Luurtsema
May 14, 2019·Expert Opinion on Therapeutic Patents·Marcello LeopoldoNicola Antonio Colabufo
Nov 26, 2011·Expert Review of Clinical Pharmacology·Andrea OrthmannReiner Zeisig
Dec 1, 2017·Current Medicinal Chemistry·Santiago VilarEugenio Uriarte
Jan 4, 2012·ChemMedChem·Marialessandra ContinoNicola Antonio Colabufo
May 3, 2016·ChemMedChem·Maria Grazia PerroneAntonio Scilimati
Jun 26, 2018·British Journal of Cancer·Shuai ChenZhi-Ming Zhang
Jan 7, 2021·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Noor Safwah DamanhuriAhmad Hasnan Mansor
Oct 21, 2016·Physiological Research·M HrubýP Štěpánek
Apr 20, 2013·Molecular Pharmaceutics·Pavitra KannanMatthew D Hall
Feb 14, 2014·Biomacromolecules·Adriana TrapaniGiovanni Puglisi
Jun 5, 2015·Molecular Pharmaceutics·Heli SavolainenGert Luurtsema
Nov 8, 2014·Journal of Medicinal Chemistry·Elena CapparelliNicola A Colabufo